DENVER, Jan. 9, 2019 /PRNewswire/ -- The costs and timelines to conduct clinical trials continue to increase, as does studycomplexity. While much of the focus in clinical trials has been on improving data quality and overall study efficiency in order to address cost/timeline/complexity issues, less attention has been paid to the impact of patient non-compliance to drug treatment.
ClinOne has introduced Dose Manager, a cost-effective mobile solution to help address this problem. Utilizing simple text messaging, automated reminders are sent to patients (as well as caregivers, as needed) to encourage them to take their medication. Similarly, research sites receive alerts to signify the need for follow-up. Sponsors and CROs benefit from reports that are designed to highlight sites where non-compliance may be a concern, thus allowing for more focused monitoring visits.
"It's estimated that 91 percent of mobile users keep their phone within arm's reach 24/7, while 90 percent of all text messages are read within three minutes of receipt, so this is a highly effective means of engaging the patient and driving better dose compliance," says Rob Bohacs, ClinOne's founder and CEO.
About ClinOneClinOne offers a complete suite of mobile and web applications to enhance patient, caregiver and site engagement. Currently, our solutions help support close to 3,000 clinical studies, across 1,900 research sites in over 50 countries. If interested in learning more or scheduling a demo, contact us. Visit www.clinone.com for more information.
View original content:http://www.prnewswire.com/news-releases/clinone-using-mobile-technology-to-improve-clinical-trial-self-dosing-compliance-300775400.html
SOURCE ClinOne Inc.
Subscribe to our Free Newsletters!